Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

$Femoral neck BMD and FRAX scores are useful for assessing fracture risk in diabetes patients$

Femoral neck BMD and FRAX scores are useful for assessing fracture risk in diabetes patients

Use of established fracture prediction methods in older patients with type 2 diabetes mellitus (DM) found that scores from these methods were associated with hip and nonspine fracture risk, and a certain score associated with higher risk of fracture compared to persons without DM, according to a study in the June 1 issue of JAMA.

1 Jun 2011

Diamyd European Phase III study in diabetes does not meet primary endpoint

Diamyd Medical AB reports that the Company has decided not to complete the follow-up period of a European Phase III study with the antigen-based therapy Diamyd.

1 Jun 2011

Type II diabetes drug may slow or stop breast cancer tumor metastasis

A protein activated by certain drugs already approved for treating Type II diabetes may slow or stop the spread of breast tumors.

1 Jun 2011

'Ultra-bad' cholesterol increases risk of heart disease in people with type 2 diabetes

Scientists from the University of Warwick have discovered why a newly found form of cholesterol seems to be 'ultra-bad', leading to increased risk of heart disease. The discovery could lead to new treatments to prevent heart disease particularly in people with type 2 diabetes and the elderly.

30 May 2011

Woman's risk of developing diabetes during pregnancy can be identified seven years before

A woman's risk of developing diabetes during pregnancy can be identified up to seven years before she becomes pregnant based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.

30 May 2011

Ultra bad cholesterol

Bad cholesterol, known as LDL is known to be sticky but this ultra –bad called MGmin-LDL is found to be stickier meaning it's more likely to attach to arterial walls. This is more dangerous because when LDL attaches to artery walls it forms fatty plaques that cause coronary heart disease (CHD). As fatty plaques grow, they narrow the arteries and reduce blood flow and also may trigger a stroke or heart attack. CHD is the most common type of heart disease and kills almost 450,000 Americans each year.

29 May 2011

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Fifty years ago, adult-onset diabetes was relatively rare, affecting less than one percent of the adult population in the United States. Today, more than 25 million Americans over the age of 20 battle the disease - an alarming 11 percent of the population.

27 May 2011

Recycling protein molecules could lead to new therapies for Alzheimer's disease

The formation of abnormal strands of protein called amyloid fibrils - associated with two dozen diseases ranging from Alzheimer's to type-2 diabetes - may not be permanent and irreversible as previously thought, scientists are reporting in the Journal of the American Chemical Society.

26 May 2011

U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly

Amylin Pharmaceuticals, Inc. today announced that the United States District Court for the Southern District of California issued a temporary restraining order (TRO) against Eli Lilly and Company relating to its litigation with respect to the Amylin / Lilly diabetes collaboration agreement.

26 May 2011

Routine assessment can help predict risk of developing diabetes during pregnancy before seven years

26 May 2011

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

GE Healthcare today announced 510k clearance of CoreScan - a widely-accessible application dedicated to quickly and accurately quantifying visceral adipose tissue, or visceral "belly" fat, during body composition analysis.

26 May 2011

Avanafil phase 3 trial in ED following radical prostatectomy meets primary endpoints

VIVUS, Inc. today announced positive results from a phase 3, placebo-controlled clinical trial of the investigational drug avanafil for the treatment of erectile dysfunction in patients following a radical prostatectomy.

25 May 2011

McDonald's reacts to protests and calls to fire Ronald

McDonald's Corp has refused to pay heed to the protesters who ask it to assess the impact of its food on childhood obesity, and said its trademark clown Ronald McDonald would be hawking Happy Meals to kids for years to come.

22 May 2011

Avandia withdrawal from shelves by November: FDA

The Food and Drugs Administration (FDA) has announced that in the beginning of November, the diabetes drug Avandia will no longer be sold in pharmacy shelves, due to the cardiovascular risks it’s causing its patients.

22 May 2011

Diet quality, not quantity, can make a difference in risk for type 2 diabetes

Small differences in diet - even without weight loss - can significantly affect risk for diabetes, according to research from the University of Alabama at Birmingham published online May 18, 2011, by the American Journal of Clinical Nutrition.

20 May 2011

Medical food resolves metabolic syndrome and cardiovascular risk factors

Researchers at the University of Florida and Metagenics Inc. today announced that a program consisting of a breakthrough medical food combined with a low-glycemic, Mediterranean-style diet is almost twice as effective as one of the best diets alone for lowering risk factors for cardiovascular disease, the leading cause of death in the U.S.

19 May 2011

Metabolex commences arhalofenate Phase 2 clinical trial for treatment of hyperuricemia and gout

Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced that it has initiated a Phase 2 clinical trial of arhalofenate (MBX-102), its product candidate for the management of hyperuricemia in patients with gout.

19 May 2011

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

University of Minnesota Medical School researchers have discovered a method to quickly and exponentially grow regulatory T-cells - also known as "suppressor cells." The new process enables replication of the cells by tens of millions in several weeks, a dramatic increase over previous duplication methods. Historically, regulatory T-cells have been difficult to replicate.

19 May 2011

Generic drugs to rule the market in the near future: Experts

According to the latest estimates for global drug sales, generic drug makers are going to be in for bumper profits. The growth in generics is expected to depress overall ‘pharma’ sales growth, as lower-priced copies replace top-dollar brand names. In fact, global sales growth could be reduced by half over the next five years, say experts.

19 May 2011

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

VIVUS, Inc. today announced that positive results from a pivotal phase 3 open-label clinical trial evaluating long-term safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction were presented at the 2011 Annual Meeting of the American Urological Association in Washington, D.C.

18 May 2011

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Femoral neck BMD and FRAX scores are useful for assessing fracture risk in diabetes patients

Diamyd European Phase III study in diabetes does not meet primary endpoint

Type II diabetes drug may slow or stop breast cancer tumor metastasis

'Ultra-bad' cholesterol increases risk of heart disease in people with type 2 diabetes

Woman's risk of developing diabetes during pregnancy can be identified seven years before

Ultra bad cholesterol

Albert Einstein College of Medicine to help shed light on causes and treatments of type 2 diabetes

Recycling protein molecules could lead to new therapies for Alzheimer's disease

U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly

Routine assessment can help predict risk of developing diabetes during pregnancy before seven years

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

Avanafil phase 3 trial in ED following radical prostatectomy meets primary endpoints

McDonald's reacts to protests and calls to fire Ronald

Avandia withdrawal from shelves by November: FDA

Diet quality, not quantity, can make a difference in risk for type 2 diabetes

Medical food resolves metabolic syndrome and cardiovascular risk factors

Metabolex commences arhalofenate Phase 2 clinical trial for treatment of hyperuricemia and gout

New technique offers successful bone marrow, organ transplant for patients with autoimmune diseases

Generic drugs to rule the market in the near future: Experts

Avanafil long-term phase 3 trial in erectile dysfunction meets primary endpoints

Industry Focus eBook - Medical device (1st edition) eBook

Modular cleanrooms: Enhancing flexibility and compliance

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Modular cleanrooms: Enhancing flexibility and compliance

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

Newsletters you may be interested in